There are 70 papers on triglyceride-glucose body mass index in aging research: 1 trial and 66 observational studies in people, 3 reviews.
70 papers study it6 more mention it66 findings
16 new papers in 30 daysSee all 76 papers on triglyceride-glucose body mass index
At a glance
Higher triglyceride-glucose body mass index is linked with early vascular aging, sarcopenia and cardiovascular disease in human observational studies. Mortality associations run in both directions: in women, higher values are linked with lower mortality below a threshold and higher mortality above it, while US adults with periodontitis show no clear link.
66 findings in 47 papers from 2022 to 2026, 20 of them since May 2026
“The highest quartiles of TyG, TyG-BMI, TyG-WC, TyG-WHtR, and TyG-WHR were significantly associated with increased breast cancer risk”
- Human trial1
- Humans66
Effects
2Mortality
no changein humans2
2 studies
Mortality
no changein humans2
Triglyceride-glucose body mass index was not clearly linked with mortality in US adults with periodontitis.
“Triglyceride-glucose-body mass index was not significantly associated with all-cause, cardiovascular disease-related, or cancer-related mortality.”
Humansin US adults with periodontitis
The Journal of international medical research
Triglyceride-glucose body mass index was not clearly linked with mortality in humans (critically ill older adults with ASCVD) (P = 0.883).
“whereas TyG-BMI was not significantly associated with mortality (P = 0.883).”
Humanscritically ill older adults with ASCVD90-dayn = 2,368
Cardiovascular diabetology
Ultrasound-defined diastolic dysfunction
no changein humans1OR 1.35
1 study
Ultrasound-defined diastolic dysfunction
no changein humans1OR 1.35
Triglyceride-glucose body mass index was not clearly linked with ultrasound-defined diastolic dysfunction in humans (Fully adjusted continuous analysis, per 1-standard deviation increase) (OR 1.35, 95% CI 0.42–4.40; P = 0.616).
“each 1-standard deviation increase was not significantly associated with ultrasound-defined diastolic dysfunction in continuous analysis”
HumansFully adjusted continuous analysis, per 1-standard deviation increasen = 1,467
Frontiers in cardiovascular medicine
Associations
42Cardiovascular disease
upin humans5HR 1.06–1.69
5 studies
Cardiovascular disease
upin humans5HR 1.06–1.69
Triglyceride-glucose body mass index is associated with cardiovascular disease in humans (Without cardiovascular disease at baseline; per 10-unit increase in TyG-BMI) (HR 1.06, 95% CI 1.04–1.07 per 10-unit increase).
“a 10-unit increase in TyG-BMI corresponded to a 6% higher risk (HR 1.06, 95% CI 1.04-1.07, p < 0.001)”
HumansWithout cardiovascular disease at baseline; per 10-unit increase in TyG-BMI9 yearsn = 8,104
Journal of health, population, and nutrition
Triglyceride-glucose body mass index is linked with a higher risk of cardiovascular disease in humans (participants with high TyG-BMI and high hsCRP vs low TyG-BMI and low hsCRP) (HR: 1.38, 95% CI: 1.18-1.62, P < 0.001).
“Participants in the high TyG-BMI and high hsCRP group demonstrated a substantially higher risk of CVD (HR: 1.38, 95% CI: 1.18-1.62, P < 0.001)”
Humansparticipants with high TyG-BMI and high hsCRP vs low TyG-BMI and low hsCRPn = 6,534
Frontiers in cardiovascular medicine
Triglyceride-glucose body mass index predicts cardiovascular disease in humans (postmenopausal women aged ≥45 years) (AUC = 0.645 vs 0.622).
“For CVD prediction, TyG-BMI (AUC = 0.645) outperformed TyG (AUC = 0.622).”
Humanspostmenopausal women aged ≥45 yearsfemalesn = 2,405
Experimental gerontology
Triglyceride-glucose body mass index is linked with a higher risk of cardiovascular disease in humans (postmenopausal women aged ≥45 years) (OR = 1.28; 95 % CI: 1.07-1.53).
“Each interquartile TyG-BMI (49.10) increase raised CVD risk by 28 % (OR = 1.28; 95 % CI: 1.07-1.53).”
Humanspostmenopausal women aged ≥45 yearsfemalesn = 2,405
Experimental gerontology
Triglyceride-glucose body mass index is linked with a higher risk of cardiovascular disease in humans (OR = 1.39, 95% CI 1.06-1.82).
“In the fully adjusted model, the increased odds of CVD for Q4 relative to Q3 was 39% (OR = 1.39, 95% CI 1.06-1.82, P = 0.019).”
Humansfemalesn = 6,343
Scientific reports
Triglyceride-glucose body mass index is linked with a higher risk of cardiovascular disease in humans (HR 1.69, 95% CI 1.44-2.00).
“higher TyG-BMI levels were associated with an increased risk of CVDs, The hazard ratio (HR) and 95% confidence interval (95% CI) for the highest quartile group were 1.69 (1.44-2.00)”
Humansaverage follow-up of 7.1 yearsn = 7,072
Frontiers in endocrinology
Cardiometabolic multimorbidity
upin humans3OR 1.61–5.72
3 studies
Cardiometabolic multimorbidity
upin humans3OR 1.61–5.72
Triglyceride-glucose body mass index is associated with cardiometabolic multimorbidity in humans (CHARLS; highest versus lowest TyG-BMI quartile; fully adjusted logistic model) (OR 5.72, 95% CI 4.52–7.22).
“the highest versus lowest TyG-BMI quartile was associated with higher odds of CMM in CHARLS (OR = 5.72, 95% CI 4.52–7.22)”
HumansCHARLS; highest versus lowest TyG-BMI quartile; fully adjusted logistic modeln = 6,426
Scientific reports
Triglyceride-glucose body mass index is associated with cardiometabolic multimorbidity in humans (Chinese adults with one cardiometabolic disease at baseline) (Q4 versus Q1: HR 1.895, 95% CI 1.574–2.282; per 1-SD increase: HR 1.315, 95% CI 1.232–1.404).
“Higher TyG-BMI was associated with an increased hazard of incident FCMD among participants without CMD at baseline and incident CMM among those with one CMD at baseline.”
HumansChinese adults with one cardiometabolic disease at baselineHighest quartile versus lowest quartileMedian follow-up: 7.0 yearsn = 2,256
Healthcare (Basel, Switzerland)
Triglyceride-glucose body mass index is associated with cardiometabolic multimorbidity in humans (Per standard deviation increase in TyG-BMI) (Adjusted OR 1.61 per standard deviation (95% CI 1.48–1.73); 5.67-fold higher risk in highest versus lowest quartiles).
“TyG-BMI demonstrated the strongest association with CMM risk, showing a 1.61-fold increase per standard deviation (adjusted OR: 1.61; 95% CI: 1.48-1.73)”
HumansPer standard deviation increase in TyG-BMI
PloS one
Sarcopenia
upin humans2OR 8.83–9.08
2 studies
Sarcopenia
upin humans2OR 8.83–9.08
Triglyceride-glucose body mass index predicts sarcopenia in humans (AUC 0.738, 95% CI 0.714-0.761 vs AIP AUC 0.648, 95% CI 0.622-0.673).
“ROC curves showed that TyG-BMI (AUC:0.738, 95% CI: 0.714 - 0.761) was more useful than AIP (AUC:0.648, 95% CI: 0.622 - 0.673) in diagnosing sarcopenia.”
Humans
Frontiers in endocrinology
Triglyceride-glucose body mass index is linked with a higher risk of sarcopenia in humans (OR 8.83, 95% CI 5.46-14.26).
“Similarly, TyG-BMI and sarcopenia were positively associated with an OR of 8.83 and a 95% CI of (5.46, 14.26).”
Humans
Frontiers in endocrinology
Triglyceride-glucose body mass index is associated with sarcopenia in humans (Q4 vs Q1) (OR = 9.08, 95% CI [2.91-28.37]).
“The TyG-BMI index demonstrated a stronger association, with the strength of this association increasing significantly as the quartile level rose”
ReviewQ4 vs Q1n = 82,798
Association between triglyceride-glucose index and sarcopenia: a meta-analysis
PeerJ
Mortality
upin humans2downin humans1HR 0.77–2.79
2 studies
Mortality
upin humans2downin humans1HR 0.77–2.79
Triglyceride-glucose body mass index is linked with a higher risk of mortality in humans (TyG-BMI above threshold of 289) (HR 1.28, 95% CI 1.13-1.46).
“Above the threshold of 289, higher TyG-BMI was associated with higher mortality risk: per SD increase HR = 1.28 (95% CI 1.13-1.46, P = 0.0002).”
HumansTyG-BMI above threshold of 289femalesn = 3,844
International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics
Triglyceride-glucose body mass index is linked with a lower risk of mortality in humans (TyG-BMI below threshold of 289) (HR 0.77, 95% CI 0.69-0.86).
“Below this point, higher TyG-BMI was associated with lower mortality risk: for each 1 SD (67.0-unit) increase in TyG-BMI, the adjusted HR for all-cause mortality was 0.77 (95% confidence interval [CI] 0.69-0.86, P < 0.0001).”
HumansTyG-BMI below threshold of 289femalesn = 3,844
International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics
Triglyceride-glucose body mass index is associated with mortality in humans (Patients with osteoporosis; fourth versus first TyG-BMI quartile) (HR 2.79, 95% CI 1.16–6.73).
“Patients in the fourth quartile (Q4) have an almost 2.8-fold increased risk of all-cause mortality compared to those in the first quartile (Q1)”
HumansPatients with osteoporosis; fourth versus first TyG-BMI quartilen = 302
Frontiers in endocrinology
Cardiovascular mortality
upin humans2HR 2.1–6.33
2 studies
Cardiovascular mortality
upin humans2HR 2.1–6.33
Triglyceride-glucose body mass index is associated with cardiovascular mortality in humans (Third versus first tertile: HR 2.10 (95% CI, 1.14-3.87); second versus first: HR 2.22 (95% CI, 1.17-4.22)).
“Higher TyG-BMI was associated with increased CV mortality in patients undergoing PD.”
HumansPatients initiating peritoneal dialysis; third versus first baseline TyG-BMI tertile; fully adjusted Cox modeln = 537
Frontiers in nutrition
Triglyceride-glucose body mass index is associated with cardiovascular mortality in humans (Patients with osteoporosis; fourth TyG-BMI quartile) (HR 6.33, 95% CI 1.19–33.80).
“The cardiovascular mortality rate is significantly higher in the TyG-BMI Q4 group (HR = 6.33, 95% CI: 1.19-33.80).”
HumansPatients with osteoporosis; fourth TyG-BMI quartilen = 302
Frontiers in endocrinology
Circadian syndrome
upin humans2
2 studies
Circadian syndrome
upin humans2
Triglyceride-glucose body mass index is associated with circadian syndrome in humans (Chinese population).
“This study provides important evidence that TyG, TyG-BMI, TyG-WC, and TyG-WHtR are significant risk factors for CircS.”
HumansChinese population4 years
Medicine
Triglyceride-glucose body mass index is linked with a higher risk of circadian syndrome in humans (fully adjusted).
“TyG-BMI, METS-IR, and AIP were positively associated with CircS risk in both analyses.”
Humansfully adjustedn = 8,392
Frontiers in nutrition
Osteoporosis
upin humans2OR 1.55
2 studies
Osteoporosis
upin humans2OR 1.55
Triglyceride-glucose body mass index is associated with osteoporosis in humans After adjustment for potential confounders (OR 1.55; P < 0.05).
“TyG-BMI, AVI, BRI, and BAI were positively associated with osteoporosis classification”
HumansAfter adjustment for potential confoundersmalesn = 702
BMC musculoskeletal disorders
Triglyceride-glucose body mass index is associated with osteoporosis in humans (Highest versus lowest TyG-BMI quartile; fully adjusted model) (HR 3.67, 95% CI 2.80–4.80).
“In fully-adjusted models, Q4 had a 3.67-fold higher osteoporosis risk vs. Q1 (95% CI: 2.80-4.80; P < 0.001).”
HumansHighest versus lowest TyG-BMI quartile; fully adjusted model4-year median follow-upn = 23,930
Frontiers in endocrinology
Diabetic kidney disease
upin humans2OR 1.019
2 studies
Diabetic kidney disease
upin humans2OR 1.019
Triglyceride-glucose body mass index is associated with diabetic kidney disease in humans (type 2 diabetes mellitus).
“Higher quartiles of TyG, TyG-BMI, and TG/HDL-C were significantly associated with increased DKD risk (trend P < 0.001).”
Humanstype 2 diabetes mellitusn = 311
Frontiers in endocrinology
Triglyceride-glucose body mass index is linked with a higher risk of diabetic kidney disease in T2DM patients (OR 1.019, 95% CI: 1.1007-1.030, P = 0.002).
“TyG-BMI (OR 1.019, 95% CI: 1.1007-1.030, P = 0.002) were independent risk factors for the occurrence of DKD in T2DM”
Humansin T2DM patients
Frontiers in endocrinology
Diabetes mellitus
upin humans2OR 5.28
2 studies
Diabetes mellitus
upin humans2OR 5.28
Triglyceride-glucose body mass index is associated with diabetes mellitus in middle-aged and older adults at high cardiovascular risk, Q4 vs Q1 (OR 5.28 (95% CI: 3.23-8.64)).
“TyG-BMI was 5.28 (95% CI: 3.23-8.64)”
Humansin middle-aged and older adults at high cardiovascular risk, Q4 vs Q1
Frontiers in public health
Triglyceride-glucose body mass index is linked with a higher risk of diabetes mellitus in humans (class 2 vs class 1) (HR 1.474).
“Compared to individuals with consistently low TyG-BMI (class 1), hazard ratios (HRs) for DM were 1.474, 2.250, and 3.142 for participants with moderately sustained and slowly increasing TyG-BMI (class 2)”
Humansclass 2 vs class 1
Diabetes research and clinical practice
Early vascular aging
upin humans1OR 1.149
1 study
Early vascular aging
upin humans1OR 1.149
Triglyceride-glucose body mass index predicts early vascular aging in humans (fully adjusted model incorporating TyG-BMI) (AUC 0.8533).
“In the fully adjusted model incorporating TyG-BMI, the area under the curve (AUC) for identifying EVA was 0.8533.”
Humansfully adjusted model incorporating TyG-BMI
BMC cardiovascular disorders
Triglyceride-glucose body mass index is linked with a higher risk of early vascular aging in humans after full adjustment (OR 1.149, 95% CI 1.083~1.231).
“each 10-unit increase in TyG-BMI was associated with a 14.9% increased risk of EVA (odds ratio [OR] 1.149, 95% confidence interval [CI] 1.083~1.231).”
Humansafter full adjustmenteach 10-unit increase
BMC cardiovascular disorders
All 42Fewer
How this record changed
Summary rewritten as its findings changed.
As it read before
Human studies associate higher triglyceride-glucose body mass index with increased prediabetes and early vascular aging risk after adjustment. A fully adjusted model incorporating this index predicts early vascular aging.
Summary written from the findings.